Insider trading

Period: 120 months Stock: NTRA + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

951 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

951 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

951 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

951 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
951 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
951 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

951 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
22 Jan 2025
Sheena Jonathan Director
Sold on a plan 2×
$160.21K 971 at 165.00
0.4%
Planned (10b5-1)
8 Jan 2025
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$1.09M 6,223 at 175.30
3.0%
Planned (10b5-1)
2 Jan 2025
Sheena Jonathan Director · indirect
Sold on a plan 6×
$478.65K 3,000 at 159.55
6.3%
Planned (10b5-1)
2 Jan 2025
Sheena Jonathan Director
Sold on a plan 3×
$430.48K 2,700 at 159.44
1.1%
Planned (10b5-1)
23 Dec 2024
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 3×
$387.51K 2,428 at 159.60
2.0%
Planned (10b5-1)
23 Dec 2024
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan 2×
$106.77K 669 at 159.60
0.6%
Planned (10b5-1)
18 Dec 2024
Sheena Jonathan Director
Sold on a plan 3×
$451.62K 2,700 at 167.27
1.0%
Planned (10b5-1)
18 Dec 2024
Sheena Jonathan Director · indirect
Sold on a plan 5×
$359.37K 2,148 at 167.30
4.4%
Planned (10b5-1)
18 Dec 2024
Sheena Jonathan Director · indirect
Sold on a plan
$142.35K 852 at 167.07
1.8%
Planned (10b5-1)
13 Dec 2024
Rabinowitz Matthew EXECUTIVE CHAIRMAN
Sold on a plan 5×
$26.52M 160,000 at 165.74
6.3%
Planned (10b5-1)
10 Dec 2024
Chapman Rowan E Director
Sold at will
$300.81K 1,767 at 170.24
22.2%
Not planned
9 Dec 2024
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$809.31K 4,858 at 166.59
4.1%
Planned (10b5-1)
2 Dec 2024
BOTHA ROELOF Director · indirect
Sold at will 5×
$14.79M 87,473 at 169.12
6.7%
Not planned
26 Nov 2024
Rabinowitz Matthew EXECUTIVE CHAIRMAN · indirect
Sold on a plan 3×
$328.35K 2,000 at 164.17
2.3%
Planned (10b5-1)
25 Nov 2024
Rabinowitz Matthew EXECUTIVE CHAIRMAN · indirect
Sold on a plan 3×
$337.03K 2,000 at 168.51
2.3%
Planned (10b5-1)
19 Nov 2024
Sold at will 2×
$1.55M 9,682 at 159.98
49.9%
Not planned
15 Nov 2024
Baynes Roy D. Director
Sold on a plan 6×
$5.44M 37,230 at 146.11
70.2%
Sold half or more
15 Nov 2024
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan 5×
$677.57K 4,628 at 146.41
2.4%
Planned (10b5-1)
15 Nov 2024
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan
$14.64K 100 at 146.35
0.1%
Planned (10b5-1)
14 Nov 2024
Sold at will 5×
$350.67K 2,212 at 158.53
10.2%
Not planned
13 Nov 2024
Sheena Jonathan Director
Sold on a plan 2×
$3.07M 20,000 at 153.54
7.1%
Planned (10b5-1)
13 Nov 2024
Sheena Jonathan Director · indirect
Sold on a plan 6×
$2.55M 16,300 at 156.48
25.4%
Planned (10b5-1)
8 Nov 2024
Sheena Jonathan Director · indirect
Sold on a plan 5×
$392.31K 3,000 at 130.77
5.1%
Planned (10b5-1)
8 Nov 2024
Sheena Jonathan Director
Sold on a plan 3×
$353.16K 2,700 at 130.80
1.0%
Planned (10b5-1)
31 Oct 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$235.96K 1,866 at 126.45
2.6%
Planned (10b5-1)
29 Oct 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$90.43K 754 at 119.93
1.1%
Planned (10b5-1)
28 Oct 2024
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan
$468.11K 3,960 at 118.21
2.0%
Planned (10b5-1)
28 Oct 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$146.34K 1,238 at 118.21
1.7%
Planned (10b5-1)
28 Oct 2024
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$141.38K 1,196 at 118.21
1.1%
Planned (10b5-1)
28 Oct 2024
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$124.95K 1,057 at 118.21
0.5%
Planned (10b5-1)
28 Oct 2024
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$109.82K 929 at 118.21
0.8%
Planned (10b5-1)
25 Oct 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$82.10K 691 at 118.81
0.9%
Planned (10b5-1)
24 Oct 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$108.94K 914 at 119.19
1.2%
Planned (10b5-1)
23 Oct 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$59.07K 496 at 119.09
0.7%
Planned (10b5-1)
22 Oct 2024
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan
$107.22K 893 at 120.07
0.5%
Planned (10b5-1)
22 Oct 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$54.51K 454 at 120.07
0.6%
Planned (10b5-1)
22 Oct 2024
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$41.90K 349 at 120.07
0.2%
Planned (10b5-1)
22 Oct 2024
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$30.74K 256 at 120.07
0.2%
Planned (10b5-1)
22 Oct 2024
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$23.89K 199 at 120.07
0.2%
Planned (10b5-1)
21 Oct 2024
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan
$206.37K 1,709 at 120.76
0.9%
Planned (10b5-1)
21 Oct 2024
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$73.42K 608 at 120.76
0.8%
Planned (10b5-1)
21 Oct 2024
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$56.39K 467 at 120.76
0.2%
Planned (10b5-1)
21 Oct 2024
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$41.30K 342 at 120.76
0.3%
Planned (10b5-1)
21 Oct 2024
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$35.50K 294 at 120.76
0.3%
Planned (10b5-1)
15 Oct 2024
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan
$589.80K 4,523 at 130.40
2.3%
Planned (10b5-1)
1 Oct 2024
Sheena Jonathan Director · indirect
Sold on a plan 4×
$377.02K 3,000 at 125.67
5.0%
Planned (10b5-1)
1 Oct 2024
Sheena Jonathan Director
Sold on a plan 3×
$339.11K 2,700 at 125.60
0.9%
Planned (10b5-1)
18 Sep 2024
Sheena Jonathan Director · indirect
Sold on a plan 4×
$2.46M 19,300 at 127.61
24.7%
Planned (10b5-1)
18 Sep 2024
Sheena Jonathan Director
Sold on a plan 2×
$344.45K 2,700 at 127.57
0.9%
Planned (10b5-1)
16 Sep 2024
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan 5×
$645.47K 5,024 at 128.48
2.5%
Planned (10b5-1)
Showing 301–350 of 951. ← Newer Page 7 of 20 Older →